Information  X 
Enter a valid email address

IndigoVision Group (IND)

  Print      Mail a friend

Wednesday 01 May, 2019

IndigoVision Group

Director/PDMR Shareholding

RNS Number : 7607X
IndigoVision Group PLC
01 May 2019
 

IndigoVision Group plc

 

("IndigoVision" or the "Company")

 

PDMR Shareholding

 

IndigoVision Group plc announces that it has been notified that on 30 April 2019 Max Thowless-Reeves, Chairman, purchased 10,000 ordinary shares in the capital of the Company ("Ordinary Shares") at a price of £1.60 per Ordinary Share.

 

Following the transaction, Max Thowless-Reeves' total shareholding in the capital of the Company is 147,383 Ordinary Shares, representing 1.96 per cent. of the voting share capital of the Company.

 

For further information:

 

IndigoVision Group plc


Chris Lea

+44 (0)131 475 7200



N+1 Singer


Sandy Fraser

+44 (0)20 7496 3176

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Max Thowless-Reeves

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IndigoVision Group plc

b)

LEI

213800UTDZWYBP2YR191

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1 pence each

 

 

GB0032654534

 

b)

Nature of the transaction

Purchase

c)

 

Price(s) and volume(s)

 

Price

Volume

£1.60

10,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

n/a

 

e)

Date of the transaction

30 April 2019

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFEIETILIIA

a d v e r t i s e m e n t